Navigation Links
Advinus Therapeutics, a TATA Enterprise, Meets Milestone in Drug Discovery Alliance
Date:1/11/2016

PUNE, India, January 11, 2016 /PRNewswire/ --

Advinus Therapeutics Ltd., the TATA promoted pharmaceutical R&D company, announced today that it has reached the third milestone in its research and development collaboration with Takeda Pharmaceutical Company Limited. The achievement of this milestone highlights the success of the collaboration.

In October 2012, Advinus and Takeda announced a multi-year, multi-project collaboration in the area of drug discovery. In this collaboration, Advinus is responsible for carrying out all the research required to identify candidate molecules for clinical development in several therapeutic areas while Takeda is responsible for the development and commercialization of these candidates. In each of the previous two years, Advinus has met predetermined milestones. The achievement of the third milestone underscores the rapid progress of the research programs over the past year, a result of the innovative solutions and the speed and quality of Advinus' efforts supported by Takeda's guidance and highly interactive engagement.

"The achievement of the third milestone by Advinus' young and talented scientists is a clear demonstration of how an effective partnership could deliver novel and effective candidates for drug development in a cost effective manner," said Kasim Mookhtiar, CEO & MD of Advinus.

About Advinus:  

Advinus Therapeutics is a research-based pharma company promoted by the TATA group. The company is the first-of-its-kind in India to offer end-to-end development services to the global pharma, agro and biotech industry while creating long-term value through internal and collaborative drug discovery. The primary focus of the company's discovery efforts are in Metabolic Diseases, Inflammatory Diseases and Pain/Neurodegeneration. Advinus also has an interest in pursuing the discovery of novel therapies for neglected or developing world diseases. Advinus' drug development operations supports and supplements the client resources at increased levels of cost-efficiency by providing services in the areas of Process Development, Drug Metabolism and Pharmacokinetics, Clinical Pharmacology, Safety Assessment, Formulation Development and Analytical R&D.

For company information, visit Advinus at http://www.advinus.com.

Media Contact:
Advinus
Joshua Daniel
Corporate Communications
+91-80-66553104
http://www.advinus.com


'/>"/>
SOURCE Advinus Therapeutics Ltd
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Advinus Therapeutics, a TATA Enterprise, Meets Year 1 Milestone in Drug Discovery Alliance
2. Advinus Therapeutics, A TATA Enterprise, Meets Milestone in Drug Discovery Alliance
3. PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Signature Therapeutics, Inc., Presents Four Scientific Posters Today at PAINWeek 2013 Meeting
6. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
7. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeutics, Inc.
8. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics, Inc.
9. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
10. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
11. Inhibikase Therapeutics, Inc. Elects Anthony Zook To The Board Of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2019)... ... September 11, 2019 , ... HOLLOWAY AMERICA, a leading manufacturer ... beverage to pharma and chemical, recently announced it will showcase its problem-solving vessels and ... , HOLLOWAY AMERICA’s first stop will be at ISPE San Diego’s 27th Life ...
(Date:9/11/2019)... ... 2019 , ... Pivot Point Consulting is excited to announce ... Partnerships team. Maris brings two decades of experience with Cerner—leading both sales ... as a Technical Implementation Leader representing the Technical Engagement Leader community. , Pivot ...
(Date:9/9/2019)... , ... September 09, 2019 , ... ... Shoreline Periodontics & Dental Implants host the latest course in their Synergy Study ... Mystic, CT and features guest speaker Dr. Peter Barndt. Synergy Study Club brings ...
Breaking Medicine Technology:
(Date:9/11/2019)... ... 11, 2019 , ... The 2019 Minnesota Anatomic Complex Knee ... Mall of America Radisson Blu. Four experts from Twin Cities Orthopedics (TCO), including ... conference, which brings together more than 100 national and international orthopedic surgeons for ...
(Date:9/11/2019)... ... 11, 2019 , ... PatientPay, the leading end-to-end patient payment ... of a patent to reduce the level of effort a medical group must ... visit patient statements. , At the core of “Instant Integration for Installment Payments” ...
(Date:9/11/2019)... ... , ... Women’s Excellence is pleased to welcome Dr. Caela ... skilled Obstetrician/Gynecologist. She approaches patients compassionately and offers comprehensive obstetrical and gynecological ... is comfortable, patient-focused, and that every patient feels her concerns have been fully ...
(Date:9/11/2019)... ... September 11, 2019 , ... Dimensional Insight®, a data ... at the annual St. Jude Walk/Run Boston. To be held on Saturday, Sept. 28 ... raise a goal of $650,000 for St. Jude Children’s Research Hospital®. , ...
(Date:9/9/2019)... ... September 09, 2019 , ... Cardinal Park Family Dental Care ... and counting. The practice offers family dentistry , laser gum disease treatment, full ... marks the 20th year that Cardinal Park Family Dental Care has provided state-of-the-art, comprehensive ...
Breaking Medicine News(10 mins):